Indivior Pharmaceuticals, Inc. 4

Christian Heidbreder, Chief Scientific Officer of Indivior Pharmaceuticals, Inc., sold 18,586 shares of common stock at about $41.14 per share on July 10, 2026 under a Rule 10b5-1 plan.

On July 10, 2026, Chief Scientific Officer Christian Heidbreder of Indivior Pharmaceuticals, Inc. sold 18,586 shares of common stock at an average price of $41.14 per share, for proceeds of approximately $765,000, under a pre-arranged Rule 10b5-1 trading plan. Following this transaction, Heidbreder retained ownership of 209,337 shares of common stock. The sale appears to be a sizable but structured disposition executed under a trading plan rather than a discretionary open-market sale.

Filing Facts

CIK

1625297

Ticker

INDV

Form

4

Source Type

fda

Accession

0002014639-26-000011

Alert Tier

6